Compile Data Set for Download or QSAR
Report error Found 1169 of affinity data for UniProtKB/TrEMBL: Q04609
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703001(US20240366813, Compound E2)
Affinity DataKd:  0.229nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703002(US20240366813, Compound E3)
Affinity DataKd:  0.550nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703003(US20240366813, Compound E4)
Affinity DataKd:  0.269nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703004(US20240366813, Compound E8)
Affinity DataKd:  0.324nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703005(US20240366813, Compound E9)
Affinity DataKd:  0.282nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703006(US20240366813, Compound E13)
Affinity DataKd:  0nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703007(US20240366813, Compound E18)
Affinity DataKd:  0.00100nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703008(US20240366813, Compound E20)
Affinity DataKd:  0nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703009(US20240366813, Compound E21)
Affinity DataKd:  0.151nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703010(US20240366813, Compound E22)
Affinity DataKd:  0.100nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703011(US20240366813, Compound E24)
Affinity DataKd:  0nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703012(US20240366813, Compound E25)
Affinity DataKd:  0.0710nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM703013(US20240366813, Compound E26)
Affinity DataKd:  0.363nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM50544833(Vipivotide tetraxetan | PSMA-617 | US20240366813, ...)
Affinity DataKd:  0.00200nMAssay Description:A Biacore 8K (Cytiva) instrument was used to determine the binding affinity of disclosed compounds to the PSMA protein (Sinobiological). The PSMA pro...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/14/2025
Entry Details
US Patent

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM730219(US20250108139, Compound DB-1)
Affinity DataKd: <100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM730224(US20250108139, Compound DB-2)
Affinity DataKd: <100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM730226(US20250108139, Compound DB-11)
Affinity DataKd: <100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM730227(US20250108139, Compound DB-12)
Affinity DataKd: <100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM730229(US20250108139, Compound DB-13)
Affinity DataKd: <100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM730231(US20250108139, Compound DB-14)
Affinity DataKd: <100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM730237(US20250108139, Compound DB-15)
Affinity DataKd: <100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM730238(US20250108139, Compound DB-16)
Affinity DataKd: <100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM730239(US20250108139, Compound DB-17)
Affinity DataKd: <100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM730240(US20250108139, Compound DB-18)
Affinity DataKd: <100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM730241(US20250108139, Compound DB-19)
Affinity DataKd: <100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM730242(US20250108139, Compound DB-20)
Affinity DataKd: <100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM730243(US20250108139, Compound DB-21)
Affinity DataKd: <100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM730244(US20250108139, Compound E-3)
Affinity DataKd: <100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM730245(US20250108139, Compound PSMA-617)
Affinity DataKd: <100nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/18/2025
Entry Details

TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755148(US20250213705, Compound 2)
Affinity DataKd:  0.208nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755149(US20250213705, Compound 5)
Affinity DataKd:  2.78nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755150(US20250213705, Compound 7)
Affinity DataKd:  5.72nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755151(US20250213705, Compound 8)
Affinity DataKd:  0.654nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755152(US20250213705, Compound 10)
Affinity DataKd:  2.02nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755153(US20250213705, Compound 12)
Affinity DataKd:  0.568nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755154(US20250213705, Compound 14)
Affinity DataKd:  4.71nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755155(US20250213705, Compound 16)
Affinity DataKd:  7.73nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755156(US20250213705, Compound 17)
Affinity DataKd:  1.65nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755157(US20250213705, Compound 21)
Affinity DataKd:  10.6nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755158(US20250213705, Compound 23)
Affinity DataKd:  120nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755159(US20250213705, Compound 24)
Affinity DataKd:  35.2nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755160(US20250213705, Compound 34)
Affinity DataKd:  0.850nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755161(US20250213705, Compound 35)
Affinity DataKd:  1.49nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755162(US20250213705, Compound 36)
Affinity DataKd:  0.996nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755163(US20250213705, Compound 37)
Affinity DataKd:  1.07nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755164(US20250213705, Compound 38)
Affinity DataKd:  1.81nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755165(US20250213705, Compound 39)
Affinity DataKd:  1.08nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755166(US20250213705, Compound 40)
Affinity DataKd:  1.62nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755167(US20250213705, Compound 41)
Affinity DataKd:  1.95nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
TargetGlutamate carboxypeptidase 2(Human)
Bivision Pharmaceuticals

US Patent
LigandPNGBDBM755168(US20250213705, Compound 48)
Affinity DataKd:  1.65E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
Displayed 1 to 50 (of 1169 total ) | Next | Last >>
Jump to: